Life over limb: Arterial access-related limb ischemic complications in 48-hour REBOA survivors.
Journal
The journal of trauma and acute care surgery
ISSN: 2163-0763
Titre abrégé: J Trauma Acute Care Surg
Pays: United States
ID NLM: 101570622
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
pubmed:
19
11
2021
medline:
28
4
2022
entrez:
18
11
2021
Statut:
ppublish
Résumé
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used in some trauma settings. Arterial access-related limb ischemic complications (ARLICs) resulting from the femoral arterial access required for REBOA are largely under reported. We sought to describe the incidence of these complications and the clinical, technical, and device factors associated with their development. This was a retrospective cohort study of records of adult trauma patients from the American Association for the Surgery of Trauma Aortic Occlusion for Resuscitation in Trauma and Acute care surgery registry between October 2013 and September 2020 who had REBOA and survived at least 48 hours. The primary outcome was ARLIC, defined as clinically relevant extremity ischemia or distal embolization. Relevant factors associated with ARLIC were also analyzed. Of 418 identified patients, 36 (8.6%) sustained at least one ARLIC; 22 with extremity ischemia, 25 with distal embolism, 11 with both. Patient demographics and injury characteristics were similar between ARLIC and no ARLIC groups. Access-related limb ischemic complication was associated with larger profile devices (p = 0.009), cutdown access technique (p = 0.02), and the presence of a pelvic external fixator/binder (p = 0.01). Patients with ARLIC had higher base deficit (p = 0.03) and lactate (p = 0.006). One hundred fifty-six patients received tranexamic acid (TXA), with 22 (14%) ARLICs. The rate of TXA use among ARLIC patients was 61% (vs. 35% TXA for non-ARLIC patients, p = 0.002). Access-related limb ischemic complication did not result in additional in-hospital mortality, however, ARLIC had prolonged hospital LOS (31 vs. 24 days, p = 0.02). Five ARLIC required surgical intervention, three patch angioplasty (and two with associated bypass), and four ARLIC limbs were amputated. Femoral artery REBOA access carries a risk of ARLIC, which is associated with unstable pelvis fractures, severe shock, and strongly with the administration of TXA. Use of lower-profile devices and close surveillance for these complications is warranted in these settings and caution should be exercised when using TXA in conjunction with REBOA. Prognostic and Epidemiologic, Level III.
Sections du résumé
BACKGROUND
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used in some trauma settings. Arterial access-related limb ischemic complications (ARLICs) resulting from the femoral arterial access required for REBOA are largely under reported. We sought to describe the incidence of these complications and the clinical, technical, and device factors associated with their development.
METHODS
This was a retrospective cohort study of records of adult trauma patients from the American Association for the Surgery of Trauma Aortic Occlusion for Resuscitation in Trauma and Acute care surgery registry between October 2013 and September 2020 who had REBOA and survived at least 48 hours. The primary outcome was ARLIC, defined as clinically relevant extremity ischemia or distal embolization. Relevant factors associated with ARLIC were also analyzed.
RESULTS
Of 418 identified patients, 36 (8.6%) sustained at least one ARLIC; 22 with extremity ischemia, 25 with distal embolism, 11 with both. Patient demographics and injury characteristics were similar between ARLIC and no ARLIC groups. Access-related limb ischemic complication was associated with larger profile devices (p = 0.009), cutdown access technique (p = 0.02), and the presence of a pelvic external fixator/binder (p = 0.01). Patients with ARLIC had higher base deficit (p = 0.03) and lactate (p = 0.006). One hundred fifty-six patients received tranexamic acid (TXA), with 22 (14%) ARLICs. The rate of TXA use among ARLIC patients was 61% (vs. 35% TXA for non-ARLIC patients, p = 0.002). Access-related limb ischemic complication did not result in additional in-hospital mortality, however, ARLIC had prolonged hospital LOS (31 vs. 24 days, p = 0.02). Five ARLIC required surgical intervention, three patch angioplasty (and two with associated bypass), and four ARLIC limbs were amputated.
CONCLUSION
Femoral artery REBOA access carries a risk of ARLIC, which is associated with unstable pelvis fractures, severe shock, and strongly with the administration of TXA. Use of lower-profile devices and close surveillance for these complications is warranted in these settings and caution should be exercised when using TXA in conjunction with REBOA.
LEVEL OF EVIDENCE
Prognostic and Epidemiologic, Level III.
Identifiants
pubmed: 34789696
doi: 10.1097/TA.0000000000003440
pii: 01586154-202204000-00013
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
723-728Informations de copyright
Copyright © 2021 American Association for the Surgery of Trauma.
Références
Hughes CW. Use of an intra-aortic balloon catheter tamponade for controlling intra-abdominal hemorrhage in man. Surgery . 1954;36(1):65–68.
Brenner ML, Moore LJ, DuBose JJ, Tyson GH, McNutt MK, Albarado RP, Holcomb JB, Scalea TM, Rasmussen TE. A clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. J Trauma Acute Care Surg . 2013;75(3):506–511.
Moore LJ, Brenner M, Kozar RA, Pasley J, Wade CE, Baraniuk MS, Scalea T, Holcomb JB. Implementation of resuscitative endovascular balloon occlusion of the aorta as an alternative to resuscitative thoracotomy for noncompressible truncal hemorrhage. J Trauma Acute Care Surg . 2015;79(4):523–530; discussion 30-2.
Davidson AJ, Russo RM, Reva VA, et al. The pitfalls of resuscitative endovascular balloon occlusion of the aorta: risk factors and mitigation strategies. J Trauma Acute Care Surg . 2018;84(1):192–202.
Burkhardt GE, Rasmussen TE, Propper BW, Lopez PL, Gifford SM, Clouse WD. A national survey of evolving management patterns for vascular injury. J Surg Educ . 2009;66(5):239–247.
DuBose JJ, Scalea TM, Brenner M, et al. The AAST prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) registry: Data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg . 2016;81(3):409–419.
Taylor JR 3rd, Harvin JA, Martin C, Holcomb JB, Moore LJ. Vascular complications from resuscitative endovascular balloon occlusion of the aorta: life over limb? J Trauma Acute Care Surg . 2017;83(1 Suppl 1):S120–S123.
Manzano-Nunez R, Orlas CP, Herrera-Escobar JP, et al. A meta-analysis of the incidence of complications associated with groin access after the use of resuscitative endovascular balloon occlusion of the aorta in trauma patients. J Trauma Acute Care Surg . 2018;85(3):626–634.
Brenner M, Inaba K, Aiolfi A, et al. Resuscitative endovascular balloon occlusion of the aorta and resuscitative thoracotomy in select patients with hemorrhagic shock: Early results from the American Association for the Surgery of Trauma’s aortic occlusion in resuscitation for trauma and acute care surgery registry. J Am Coll Surg . 2018;226(5):730–740.
Teeter WA, Matsumoto J, Idoguchi K, Kon Y, Orita T, Funabiki T, Brenner ML, Matsumura Y. Smaller introducer sheaths for REBOA may be associated with fewer complications. J Trauma Acute Care Surg . 2016;81(6):1039–1045.
Wasicek PJ, Teeter WA, Yang S, Hu P, Hoehn MR, Stein DM, Scalea TM, Brenner ML. Life over limb: lower extremity ischemia in the setting of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). Am Surg . 2018;84(6):971–977.
Levin SR, Farber A, Burke PA, Brahmbhatt TS, Richman AP, Twomey KE, Siracuse JJ. The majority of major amputations after resuscitative endovascular balloon occlusion of the aorta are associated with preadmission trauma. J Vasc Surg . 2021;74(2):467–76.e4.
Saito N, Matsumoto H, Yagi T, Hara Y, Hayashida K, Motomura T, Mashiko K, Iida H, Yokota H, Wagatsuma Y. Evaluation of the safety and feasibility of resuscitative endovascular balloon occlusion of the aorta. J Trauma Acute Care Surg . 2015;78(5):897–903; discussion 4.
Power A, Parekh A, Scallan O, Smith S, Novick T, Parry N, Moore L. Size matters: first-in-human study of a novel 4 French REBOA device. Trauma Surg Acute Care Open . 2021;6(1):e000617.
Asmar S, Bible L, Chehab M, Tang A, Khurrum M, Douglas M, Castanon L, Kulvatunyou N, Joseph B. Resuscitative endovascular balloon occlusion of the aorta vs pre-peritoneal packing in patients with pelvic fracture. J Am Coll Surg . 2021;232(1):17–26.e2.
Davis JW, Sue LP, Dirks RC, Kaups KL, Kwok AM, Wolfe MM, Lilienstein JT, Bilello JF. Admission base deficit is superior to lactate in identifying shock and resuscitative needs in trauma patients. Am J Surg . 2020;220(6):1480–1484.
Shakur H, Roberts I, Bautista R, et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet . 2010;376(9734):23–32.
CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet . 2019;394(10210):1713–1723.
Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg . 2012;147(2):113–119.
Guyette FX, Brown JB, Zenati MS, et al. Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg . 2020;56(1):11–20.
Herbert K, Buchbinder L, Seshachellam V, Lee L. Resuscitative endovascular balloon occlusion of the aorta and concomitant tranexamic acid for cesarean hysterectomy complicated by common femoral artery thrombosis: a case report. Cureus . 2020;12(10):e11197.